Tzu-Yin Lin
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$4.7MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $4.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 27, 2024 | NIH | SBIR Phase II Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma | $720K | THERANOSTEC INC |
| Apr 18, 2023 | NIH | SBIR Phase II Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma | $850K | THERANOSTEC INC |
| Sep 8, 2022 | NIH | SBIR Phase I Sub-100 nm and scalable self-therapeutic nanoparticles to target autophagy in pancreatic cancer | $400K | THERANOSTEC INC |
| Aug 10, 2021 | NIH | SBIR Phase II Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma | $480K | THERANOSTEC INC |
| Aug 14, 2020 | NIH | SBIR Phase II Extremely long tumor retention, on-demand releasing Nano-Taxel for eradicating ovarian cancers | $1.5M | THERANOSTEC INC |
| Aug 27, 2019 | NIH | SBIR Phase II Extremely long tumor retention, on-demand releasing Nano-Taxel for eradicating ovarian cancers | $503K | THERANOSTEC INC |
| Aug 5, 2019 | NIH | SBIR Phase I Transformable nano-theranostics for image-guided interventions in head and neck squamous cell carcinoma | $300K | THERANOSTEC INC |
Peer ranks
Federal funding#294
Awards as PI#250
Patents#273
Companies
- THERANOSTEC INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.